share_log

Investors Are Selling off Guangzheng Eye Hospital Group (SZSE:002524), Lack of Profits No Doubt Contribute to Shareholders Three-year Loss

Investors Are Selling off Guangzheng Eye Hospital Group (SZSE:002524), Lack of Profits No Doubt Contribute to Shareholders Three-year Loss

投资者抛售光正眼科医院集团(深交所股票代码:002524),利润不足无疑导致股东三年亏损
Simply Wall St ·  2023/10/24 02:09

Many investors define successful investing as beating the market average over the long term. But the risk of stock picking is that you will likely buy under-performing companies. We regret to report that long term Guangzheng Eye Hospital Group Co., Ltd. (SZSE:002524) shareholders have had that experience, with the share price dropping 47% in three years, versus a market decline of about 13%. The last week also saw the share price slip down another 13%. This could be related to the recent financial results - you can catch up on the most recent data by reading our company report.

许多投资者将成功的投资定义为长期超过市场平均水平。但选股的风险是,你可能会买入表现不佳的公司。我们很遗憾地报告这一长期的光正眼科医院集团有限公司。(SZSE:002524)股东有过这样的经历,股价在三年内下跌了47%,而市场跌幅约为13%。上周,该公司股价又下跌了13%。这可能与最近的财务业绩有关-您可以通过阅读我们的公司报告来了解最新的数据。

With the stock having lost 13% in the past week, it's worth taking a look at business performance and seeing if there's any red flags.

鉴于该公司股价在过去一周下跌了13%,我们有必要看看它的业务表现,看看是否有任何危险信号。

See our latest analysis for Guangzheng Eye Hospital Group

查看我们对光正眼科医院集团的最新分析

Given that Guangzheng Eye Hospital Group didn't make a profit in the last twelve months, we'll focus on revenue growth to form a quick view of its business development. Shareholders of unprofitable companies usually expect strong revenue growth. As you can imagine, fast revenue growth, when maintained, often leads to fast profit growth.

鉴于光正眼科医院集团在过去12个月中没有盈利,我们将重点关注收入增长,以快速了解其业务发展。未盈利公司的股东通常预期营收增长强劲。正如你可以想象的那样,快速的收入增长,如果保持下去,往往会带来快速的利润增长。

Over the last three years, Guangzheng Eye Hospital Group's revenue dropped 4.1% per year. That is not a good result. The annual decline of 14% per year in that period has clearly disappointed holders. That makes sense given the lack of either profits or revenue growth. Of course, sentiment could become too negative, and the company may actually be making progress to profitability.

在过去的三年里,光正眼科医院集团的收入每年下降4.1%。这不是一个好结果。在此期间,每年14%的跌幅显然让持有者感到失望。考虑到既没有利润也没有收入增长,这是有道理的。当然,市场情绪可能会变得过于负面,该公司实际上可能正在盈利方面取得进展。

You can see how earnings and revenue have changed over time in the image below (click on the chart to see the exact values).

您可以在下图中看到收益和收入随时间的变化(单击图表查看确切的值)。

earnings-and-revenue-growth
SZSE:002524 Earnings and Revenue Growth October 24th 2023
深交所:2023年10月24日收益和收入增长002524

Balance sheet strength is crucial. It might be well worthwhile taking a look at our free report on how its financial position has changed over time.

资产负债表的强健至关重要。也许很值得一看我们的免费报告其财务状况如何随着时间的推移而发生变化。

A Different Perspective

不同的视角

We regret to report that Guangzheng Eye Hospital Group shareholders are down 15% for the year. Unfortunately, that's worse than the broader market decline of 6.4%. Having said that, it's inevitable that some stocks will be oversold in a falling market. The key is to keep your eyes on the fundamental developments. Longer term investors wouldn't be so upset, since they would have made 7%, each year, over five years. It could be that the recent sell-off is an opportunity, so it may be worth checking the fundamental data for signs of a long term growth trend. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. For instance, we've identified 1 warning sign for Guangzheng Eye Hospital Group that you should be aware of.

我们遗憾地报告,光正眼科医院集团股东今年以来下跌了15%。不幸的是,这比大盘6.4%的跌幅还要糟糕。话虽如此,在下跌的市场中,一些股票不可避免地会被超卖。关键是要密切关注基本面的发展。较长期的投资者不会如此沮丧,因为他们在五年内每年会获得7%的收益。最近的抛售可能是一个机会,因此可能值得查看基本面数据,以寻找长期增长趋势的迹象。虽然值得考虑市场状况对股价可能产生的不同影响,但还有其他更重要的因素。例如,我们已经确定广正眼科医院集团1块警示牌这一点你应该知道。

We will like Guangzheng Eye Hospital Group better if we see some big insider buys. While we wait, check out this free list of growing companies with considerable, recent, insider buying.

如果我们看到一些大的内部收购,我们会更喜欢光正眼科医院集团。在我们等待的时候,看看这个免费最近有大量内幕收购的成长型公司名单。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.

请注意,本文引用的市场回报反映了目前在中国交易所交易的股票的市场加权平均回报。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有什么反馈吗?担心内容吗? 保持联系直接与我们联系。或者,也可以给编辑组发电子邮件,地址是implywallst.com。
本文由Simply Wall St.撰写,具有概括性。我们仅使用不偏不倚的方法提供基于历史数据和分析师预测的评论,我们的文章并不打算作为财务建议。它不构成买卖任何股票的建议,也没有考虑你的目标或你的财务状况。我们的目标是为您带来由基本面数据驱动的长期重点分析。请注意,我们的分析可能不会将最新的对价格敏感的公司公告或定性材料考虑在内。Simply Wall St.对上述任何一只股票都没有持仓。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发